Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian G Hartinger

Showing results (21-30 of 190) with videos related to

Pageof 19
Sort By:
Journal of Inorganic Biochemistry|March 20, 2016
Biodistribution of the novel anticancer drug sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] KP-1339/IT139 in nude BALB/c mice and implications on its mode of actionAnna K Bytzek, Gunda Koellensperger, Bernhard K Keppler, et al.
Inorganic Chemistry|December 11, 2007
Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approachChristian G Hartinger, Yury O Tsybin, Jens Fuchser, et al.
Metallomics : Integrated Biometal Science|June 25, 2022
The aqueous stability and interactions of organoruthenium compounds with serum proteins, cell culture medium, and human serumMie Riisom, Liam Eade, William D J Tremlett, et al.
Journal of Inorganic Biochemistry|July 26, 2017
Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assayChristian Artner, Hannah U Holtkamp, Christian G Hartinger, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|July 4, 2008
The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathwaysSoumya Chatterjee, Subhadip Kundu, Arindam Bhattacharyya, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 6, 2010
Metabolization of [Ru(eta(6)-C (6)H (5)CF (3))(pta)Cl (2)]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligandAlexander E Egger, Christian G Hartinger, Anna K Renfrew, et al.
Chemmedchem|March 20, 2014
Efficiently detecting metallodrug-protein adducts: ion trap versus time-of-flight mass analyzersSamuel M Meier, Maria V Babak, Bernhard K Keppler, et al.
Chemistry & Biodiversity|September 15, 2012
Organometallic ruthenium and osmium compounds of pyridin-2- and -4-ones as potential anticancer agentsHelena Henke, Wolfgang Kandioller, Muhammad Hanif, et al.
Electrophoresis|May 16, 2019
Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albuminMatthew P Sullivan, Stuart J Morrow, David C Goldstone, et al.
Chemical Society Reviews|May 11, 2013
Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugsChristian G Hartinger, Michael Groessl, Samuel M Meier, et al.
Pageof 19

Showing results (21-30 of 190) with videos related to

Sort By:
Pageof 19
Journal of Inorganic Biochemistry|March 20, 2016
Biodistribution of the novel anticancer drug sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] KP-1339/IT139 in nude BALB/c mice and implications on its mode of actionAnna K Bytzek, Gunda Koellensperger, Bernhard K Keppler, et al.
Inorganic Chemistry|December 11, 2007
Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approachChristian G Hartinger, Yury O Tsybin, Jens Fuchser, et al.
Metallomics : Integrated Biometal Science|June 25, 2022
The aqueous stability and interactions of organoruthenium compounds with serum proteins, cell culture medium, and human serumMie Riisom, Liam Eade, William D J Tremlett, et al.
Journal of Inorganic Biochemistry|July 26, 2017
Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assayChristian Artner, Hannah U Holtkamp, Christian G Hartinger, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|July 4, 2008
The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathwaysSoumya Chatterjee, Subhadip Kundu, Arindam Bhattacharyya, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|April 6, 2010
Metabolization of [Ru(eta(6)-C (6)H (5)CF (3))(pta)Cl (2)]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligandAlexander E Egger, Christian G Hartinger, Anna K Renfrew, et al.
Chemmedchem|March 20, 2014
Efficiently detecting metallodrug-protein adducts: ion trap versus time-of-flight mass analyzersSamuel M Meier, Maria V Babak, Bernhard K Keppler, et al.
Chemistry & Biodiversity|September 15, 2012
Organometallic ruthenium and osmium compounds of pyridin-2- and -4-ones as potential anticancer agentsHelena Henke, Wolfgang Kandioller, Muhammad Hanif, et al.
Electrophoresis|May 16, 2019
Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albuminMatthew P Sullivan, Stuart J Morrow, David C Goldstone, et al.
Chemical Society Reviews|May 11, 2013
Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugsChristian G Hartinger, Michael Groessl, Samuel M Meier, et al.
Pageof 19